Nuveen Asset Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-337,165
| Closed | -$8.13M | – | 3358 |
|
|
2023
Q1 | $8.13M | Sell |
337,165
-74,141
| -18% | -$1.79M | ﹤0.01% | 1617 |
|
|
2022
Q4 | $4.35M | Buy |
411,306
+29,409
| +8% | +$311K | ﹤0.01% | 1995 |
|
|
2022
Q3 | $1.72M | Sell |
381,897
-739
| -0.2% | -$3.33K | ﹤0.01% | 2475 |
|
|
2022
Q2 | $1.53M | Sell |
382,636
-62,906
| -14% | -$252K | ﹤0.01% | 2579 |
|
|
2022
Q1 | $3.29M | Sell |
445,542
-418
| -0.1% | -$3.09K | ﹤0.01% | 2279 |
|
|
2021
Q4 | $2.51M | Buy |
445,960
+8,335
| +2% | +$46.9K | ﹤0.01% | 2461 |
|
|
2021
Q3 | $2.92M | Buy |
437,625
+209,786
| +92% | +$1.4M | ﹤0.01% | 2498 |
|
|
2021
Q2 | $1.92M | Sell |
227,839
-117,027
| -34% | -$986K | ﹤0.01% | 2731 |
|
|
2021
Q1 | $3.62M | Buy |
344,866
+3,137
| +0.9% | +$32.9K | ﹤0.01% | 2328 |
|
|
2020
Q4 | $5.79M | Sell |
341,729
-32,570
| -9% | -$552K | ﹤0.01% | 1992 |
|
|
2020
Q3 | $4.8M | Buy |
374,299
+207,787
| +125% | +$2.67M | ﹤0.01% | 1937 |
|
|
2020
Q2 | $2.35M | Buy |
+166,512
| New | +$2.35M | ﹤0.01% | 2272 |
|